Crossmark

Efficacy of intralesional acyclovir versus quadrivalent human papillomavirus vaccine for treatment of recalcitrant cutaneous warts: a clinical trial

Published Online: 2025-03-08

Authors

Elyamany, Mona Ibrahim

Obaid, Zakaria Mahran

Fouda, Ibrahim https://orcid.org/0000-0002-4756-5100
License Information

Text and Data Mining valid from 2025-03-08

Version of Record valid from 2025-03-08
More Information

Article History

Received: 26 December 2024

Revised: 2 February 2025

Accepted: 12 February 2025

First Online: 8 March 2025

Declarations

:

: The authors declare no competing interests.

Document is current